Indication

Acute Staph. aureus sinusitis

Acute *Staph. Read more about Acute Staph. aureus sinusitis

136 drugs 82 manufacturers

Advertisement

Drugs that treat it

Common Acute Staph. aureus sinusitis therapies.

Showing 73–81 of 136 drugs

Filter & compare in the drug finder →Opens the drug finder with Acute Staph. aureus sinusitis preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Acute Staph. aureus sinusitis.

Acute *Staph.

aureus* sinusitis is an acute bacterial infection of the paranasal sinus mucosa caused specifically by *Staphylococcus aureus*.

It primarily affects the respiratory system in pediatric and adult populations, often arising following ostiomeatal obstruction, viral upper respiratory illness, or nosocomial predisposing factors.

Pathophysiologically, localized mucosal inflammation and impaired mucociliary clearance facilitate colonization, mucosal invasion, and suppurative inflammation driven by staphylococcal virulence factors and toxins.

Clinically, it is characterized by symptoms lasting under four weeks, including purulent rhinorrhea, nasal congestion, facial pain or pressure, and fever, with an elevated potential for invasive local complications or treatment challenges associated with antibiotic-resistant strains.

Personalize your experience

Follow Acute Staph. aureus sinusitis and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it